{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:05:46Z","timestamp":1788833146039,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.celrep.2021.109957","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T01:49:14Z","timestamp":1635904154000},"page":"109957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8141-2864","authenticated-orcid":false,"given":"Junfeng","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6006-2620","authenticated-orcid":false,"given":"Atif","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Armando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Gimple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2129-7937","authenticated-orcid":false,"given":"Hui","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-3422","authenticated-orcid":false,"given":"Ivy Tsz-Lo","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0728-9620","authenticated-orcid":false,"given":"Yuchao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichiro","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis J.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7232-4264","authenticated-orcid":false,"given":"Derek A.","family":"Wainwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1909-4361","authenticated-orcid":false,"given":"Frank B.","family":"Furnari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy N.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy F.","family":"Cloughesy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harley I.","family":"Kornblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8950-9169","authenticated-orcid":false,"given":"Oswald","family":"Quehenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Rzhetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F.","family":"Cravatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4560-2211","authenticated-orcid":false,"given":"Paul S.","family":"Mischel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2021.109957_bib1","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox regression-model for counting-processes: a large sample study","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann. Stat."},{"key":"10.1016\/j.celrep.2021.109957_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cell.2012.12.030","article-title":"Architecture and membrane interactions of the EGF receptor","volume":"152","author":"Arkhipov","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109957_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cmet.2019.06.014","article-title":"Oncogene amplification in growth factor signaling pathways renders cancers dependent on membrane lipid remodeling","volume":"30","author":"Bi","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2021.109957_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41568-019-0226-5","article-title":"Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets","volume":"20","author":"Bi","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2021.109957_bib5","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2021.109957_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0893-133X(00)00116-0","article-title":"Brain pharmacokinetics and tissue distribution in\u00a0vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy","volume":"23","author":"Bolo","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.celrep.2021.109957_bib7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109957_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2021.109957_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/COC.0b013e3181e8461a","article-title":"Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival: the mayo clinic experience","volume":"34","author":"Caudill","year":"2011","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2021.109957_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2021.109957_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/MCB.00719-15","article-title":"Inhibition of Acid Sphingomyelinase Depletes Cellular Phosphatidylserine and Mislocalizes K-Ras from the Plasma Membrane","volume":"36","author":"Cho","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.celrep.2021.109957_bib12","doi-asserted-by":"crossref","first-page":"e17635","DOI":"10.7554\/eLife.17635","article-title":"Rac1-mediated membrane raft localization of PI3K\/p110\u03b2 is required for its activation by GPCRs or PTEN loss","volume":"5","author":"Cizmecioglu","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2021.109957_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pathol-011110-130324","article-title":"Glioblastoma: from molecular pathology to targeted treatment","volume":"9","author":"Cloughesy","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.celrep.2021.109957_bib14","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jama.2018.10136","article-title":"Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness","volume":"320","author":"Corrigan-Curay","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2021.109957_bib15","first-page":"235","article-title":"Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling","volume":"1","author":"Corsello","year":"2020","journal-title":"Nat. Can."},{"key":"10.1016\/j.celrep.2021.109957_bib16","doi-asserted-by":"crossref","first-page":"e02882","DOI":"10.7554\/eLife.02882","article-title":"Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis","volume":"3","author":"Das","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2021.109957_bib17","series-title":"DepMap 20Q1 Public. figshare","year":"2020"},{"key":"10.1016\/j.celrep.2021.109957_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ccell.2016.05.002","article-title":"Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells","volume":"29","author":"Dolma","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.109957_bib19","series-title":"PROZAC (fluoxetine) [package insert].","year":"2017"},{"key":"10.1016\/j.celrep.2021.109957_bib20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.cell.2018.12.042","article-title":"Molecular Discrimination between Two Conformations of Sphingomyelin in Plasma Membranes","volume":"176","author":"Endapally","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109957_bib21","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.celrep.2021.109957_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109957_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional Hazards Tests and Diagnostics Based on Weighted Residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1016\/j.celrep.2021.109957_bib24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nm.3214","article-title":"Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs","volume":"19","author":"Gulbins","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.109957_bib25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1158\/2159-8290.CD-11-0102","article-title":"An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR\/AKT\/SREBP-1\/LDLR-dependent pathway","volume":"1","author":"Guo","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2021.109957_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2021.109957_bib82","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.cell.2016.10.039","article-title":"Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth","volume":"167","author":"Hu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109957_bib27","series-title":"IBM MarketScan Research Databases for Life Sciences Researchers (white paper).","year":"2018"},{"key":"10.1016\/j.celrep.2021.109957_bib28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jama.2017.9991","article-title":"Multidimensional Evidence Generation and FDA Regulatory Decision Making: Defining and Using \u201cReal-World\u201d Data","volume":"318","author":"Jarow","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2021.109957_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric-Estimation from Incomplete Observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J.\u00a0Am. Stat. Assoc."},{"key":"10.1016\/j.celrep.2021.109957_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1176\/jnp.5.3.322","article-title":"Human brain fluoxetine concentrations","volume":"5","author":"Karson","year":"1993","journal-title":"J.\u00a0Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.celrep.2021.109957_bib31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41588-020-0678-2","article-title":"Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers","volume":"52","author":"Kim","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2021.109957_bib32","doi-asserted-by":"crossref","first-page":"11389","DOI":"10.1158\/0008-5472.CAN-06-2318","article-title":"Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling","volume":"66","author":"Kobayashi","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2021.109957_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1021\/jm070524a","article-title":"Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model","volume":"51","author":"Kornhuber","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.celrep.2021.109957_bib34","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/neuonc\/now045","article-title":"Large-scale assessment of the gliomasphere model system","volume":"18","author":"Laks","year":"2016","journal-title":"Neuro-oncol."},{"key":"10.1016\/j.celrep.2021.109957_bib35","doi-asserted-by":"crossref","first-page":"a020768","DOI":"10.1101\/cshperspect.a020768","article-title":"The EGFR family: not so prototypical receptor tyrosine kinases","volume":"6","author":"Lemmon","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.celrep.2021.109957_bib36","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"L\u00e9vesque","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.celrep.2021.109957_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.1174621","article-title":"Lipid rafts as a membrane-organizing principle","volume":"327","author":"Lingwood","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.109957_bib38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2021.109957_bib39","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1158\/0008-5472.CAN-07-0589","article-title":"Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab","volume":"67","author":"Lu","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2021.109957_bib40","first-page":"5355","article-title":"Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR","volume":"61","author":"Luwor","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2021.109957_bib41","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3892\/or.2016.4860","article-title":"Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells","volume":"36","author":"Ma","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.celrep.2021.109957_bib42","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1194\/jlr.D400041-JLR200","article-title":"A simplified method for the preparation of detergent-free lipid rafts","volume":"46","author":"Macdonald","year":"2005","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.celrep.2021.109957_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nn.4190","article-title":"An epigenetic gateway to brain tumor cell identity","volume":"19","author":"Mack","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2021.109957_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.bjp.0705936","article-title":"Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines","volume":"143","author":"Mah\u00e9","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.celrep.2021.109957_bib45","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1038\/s41467-018-06916-5","article-title":"Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration","volume":"9","author":"McFarland","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.109957_bib46","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cell.2019.10.039","article-title":"Functional Enhancers Shape Extrachromosomal Oncogene Amplifications","volume":"179","author":"Morton","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109957_bib47","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.molcel.2019.08.030","article-title":"Histone Variant and Cell Context Determine H3K27M Reprogramming of the Enhancer Landscape and Oncogenic State","volume":"76","author":"Nagaraja","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2021.109957_bib48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.1241328","article-title":"Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA","volume":"343","author":"Nathanson","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.109957_bib49","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1038\/ncomms6690","article-title":"Extrachromosomal driver mutations in glioblastoma and low-grade glioma","volume":"5","author":"Nikolaev","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.109957_bib50","doi-asserted-by":"crossref","first-page":"e1425","DOI":"10.1038\/cddis.2014.384","article-title":"A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy","volume":"5","author":"Noack","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2021.109957_bib51","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","article-title":"Quantitative Proteomics of the Cancer Cell Line Encyclopedia","volume":"180","author":"Nusinow","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109957_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2021.109957_bib53","doi-asserted-by":"crossref","first-page":"100025","DOI":"10.1016\/j.bbih.2019.100025","article-title":"A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors","volume":"2","author":"Otto-Meyer","year":"2020","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.celrep.2021.109957_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nprot.2011.419","article-title":"Quantitative imaging of membrane lipid order in cells and organisms","volume":"7","author":"Owen","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2021.109957_bib55","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0006-3495(97)78887-8","article-title":"Two-photon fluorescence microscopy of laurdan generalized polarization domains in model and natural membranes","volume":"72","author":"Parasassi","year":"1997","journal-title":"Biophys. J."},{"key":"10.1016\/j.celrep.2021.109957_bib56","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2021.109957_bib57","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2013.08.003","article-title":"Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase","volume":"24","author":"Petersen","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.109957_bib58","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The Microenvironmental Landscape of Brain Tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.109957_bib59","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic Signaling Pathways in The Cancer Genome Atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109957_bib60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/biomet\/67.1.145","article-title":"Chi-Squared Goodness-of-Fit Tests for the Proportional Hazards Regression Model","volume":"67","author":"Schoenfeld","year":"1980","journal-title":"Biometrika"},{"key":"10.1016\/j.celrep.2021.109957_bib61","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.febslet.2009.11.083","article-title":"Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease","volume":"584","author":"Schuchman","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.celrep.2021.109957_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","article-title":"Types A and B Niemann-Pick disease","volume":"120","author":"Schuchman","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.celrep.2021.109957_bib63","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrm.2017.16","article-title":"The mystery of membrane organization: composition, regulation and roles of lipid rafts","volume":"18","author":"Sezgin","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2021.109957_bib64","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-World Evidence - What Is It and What Can It Tell Us?","volume":"375","author":"Sherman","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2021.109957_bib65","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1158\/0008-5472.CAN-11-1245","article-title":"DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance","volume":"71","author":"Squatrito","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2021.109957_bib66","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.109957_bib67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1357","article-title":"Immortal time bias in observational studies of drug effects","volume":"16","author":"Suissa","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.celrep.2021.109957_bib68","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/aje\/kwn135","article-title":"Immeasurable time bias in observational studies of drug effects on mortality","volume":"168","author":"Suissa","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"W1","key":"10.1016\/j.celrep.2021.109957_bib69","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2021.109957_bib70","series-title":"Modeling Survival Data: Extending the Cox Model","first-page":"39","article-title":"The Cox Model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.celrep.2021.109957_bib71","series-title":"Package \u2018 survival","author":"Therneau","year":"2015"},{"key":"10.1016\/j.celrep.2021.109957_bib72","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature21356","article-title":"Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity","volume":"543","author":"Turner","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109957_bib73","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10545-005-0105-y","article-title":"A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A\/B, with specificity of natural sphingomyelinase substrate","volume":"28","author":"van Diggelen","year":"2005","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.celrep.2021.109957_bib74","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm2330","article-title":"Membrane lipids: where they are and how they behave","volume":"9","author":"van Meer","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2021.109957_bib75","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ccell.2016.09.008","article-title":"An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers","volume":"30","author":"Villa","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.109957_bib76","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.1158\/0008-5472.CAN-04-4392","article-title":"Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2021.109957_bib77","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro-oncol."},{"key":"10.1016\/j.celrep.2021.109957_bib78","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrd1821","article-title":"Case history: the discovery of fluoxetine hydrochloride (Prozac)","volume":"4","author":"Wong","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2021.109957_bib79","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-018-1912-1","article-title":"Structure and evolution of double minutes in diagnosis and relapse brain tumors","volume":"137","author":"Xu","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2021.109957_bib80","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/aje\/kwi307","article-title":"Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods","volume":"162","author":"Zhou","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.celrep.2021.109957_bib81","doi-asserted-by":"crossref","first-page":"80853","DOI":"10.18632\/oncotarget.20714","article-title":"The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721014340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721014340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:30:21Z","timestamp":1761910221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124721014340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2211124721014340"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2021.109957","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.16.435487","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2021.109957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"109957"}}